F. Dotta

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
F Dotta, F. Dotta, Francesco Dotta
Publication record
242 papers · 13,488 citations · H-index 51

PAPERS

Multi-omics study in Rett syndrome to investigate the role of the MECP2 gene mutation in redox regulatory pathways
20230 citationsauthor #8
A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis–Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes
20235 citationsauthor #15
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
2023134 citationsauthor #13
227-LB: Kynurenine Pathway Is Associated with Preservation of Beta-Cell Function in Autoimmune Diabetes
20230 citationsauthor #10
Gene expression signature predicts rate of type 1 diabetes progression
202314 citationsauthor #67
Angiotensin I‐converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors
20232 citationsauthor #10
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
202311 citationsauthor #22
A set of circulating microRNAs belonging to the 14q32 chromosomic locus identifies two clinically and phenotypically different subgroups of individuals with recent onset Stage 3 type 1 diabetes
20230 citationsauthor #19
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes
202232 citationsauthor #55
Diabetic Mastopathy Coexisting with Appendix Neuroendocrine Tumor in A Type 1 Diabetic Woman: A Case Report
20220 citationsauthor #5
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis
202226 citationsauthor #10
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes
202234 citationsauthor #19
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment
20229 citationsauthor #10
NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes
202212 citationsauthor #5
Mutations Specific Redox Regulation Pathway In Rett Syndrome By The Use Of Transcriptomics And Proteomics Approaches
20220 citationsauthor #8
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 2.0
20226 citationsauthor #3
Risk of intraocular pressure increase with intravitreal injections of Vascular Endothelial Growth Factor Inhibitors: a cohort study.
202213 citationsauthor #5
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside.
202235 citationsauthor #12
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes
202222 citationsauthor #48
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation
202217 citationsauthor #14
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II
20227 citationsauthor #9
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests
20210 citationsauthor #9
Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools
202134 citationsauthor #9
Prognostic bioindicators in severe COVID-19 patients
202137 citationsauthor #15
290-OR: Altered In-Situ Expression of Proinsulin-Insulin in Pancreatic Islets Reflects Metabolic and Molecular Defects in Type 2 Diabetic and Glucose-Intolerant Living Donors
20210 citationsauthor #14
CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes
202119 citationsauthor #16
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy
20215 citationsauthor #9
The Landscape of microRNAs in βCell: Between Phenotype Maintenance and Protection
202114 citationsauthor #8
Reduced miR-184-3p expression occurring in Type 2 diabetic pancreatic islets protects β-cells from lipotoxic and proinflammatory apoptosis via a CRTC1-dependent mechanism
20212 citationsauthor #14
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors
202110 citationsauthor #13
Screening of postpartum diabetes in women with gestational diabetes: high-risk subgroups and areas for improvements—the STRONG observational study
202114 citationsauthor #90
Correction to: Screening of postpartum diabetes in women with gestational diabetes: high‑risk subgroups and areas for improvements—the STRONG observational study
20211 citationsauthor #90
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab
202121 citationsauthor #10
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells
202119 citationsauthor #18
Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study
202127 citationsauthor #10
Non-Coding RNAs: Novel Players in Insulin Resistance and Related Diseases
202122 citationsauthor #9
Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples
202112 citationsauthor #12
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis.
202013 citationsauthor #13
SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature
2020174 citationsauthor #14
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes
202025 citationsauthor #13
Intestinal Delivery of Proinsulin and IL-10 via Lactococcus lactis Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis
202027 citationsauthor #15
Diabetes vulnerability in Rome
20200 citationsauthor #6
MicroRNA Expression in the Aqueous Humor of Patients with Diabetic Macular Edema
202022 citationsauthor #14
1795-P: Proinsulin-Insulin Pancreatic Islets In-situ Expression Mirrors Metabolic Defects Observed in Type 2 Diabetic and Glucose Intolerant Living Donors
20200 citationsauthor #12
Prevention and treatment of autoimmune diseases with plant virus nanoparticles
202028 citationsauthor #13
Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology
202015 citationsauthor #4
Fostering improved human islet research: a European perspective
201916 citationsauthor #15
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage
201919 citationsauthor #3
Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
2019134 citationsauthor #4
Lymphocyte-Derived Exosomal MicroRNAs Promote Pancreatic β Cell Death and May Contribute to Type 1 Diabetes Development.
2019236 citationsauthor #16
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus
201961 citationsauthor #8
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes
201938 citationsauthor #6
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
201925 citationsauthor #8
G-protein-coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives.
201819 citationsauthor #4
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes
201897 citationsauthor #7
Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors.
2018182 citationsauthor #25
Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes
20185 citationsauthor #5
Circulating MicroRNAs as Biomarkers of Gestational Diabetes Mellitus: Updates and Perspectives
201864 citationsauthor #8
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes.
2018149 citationsauthor #21
Circulating MicroRNAs in Elderly Type 2 Diabetic Patients
201841 citationsauthor #8
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options.
201829 citationsauthor #8
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism
201856 citationsauthor #13
Urban diabetes: the case of the metropolitan area of Rome
20186 citationsauthor #11
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
20181,371 citationsauthor #319
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells
201863 citationsauthor #7
MicroRNA Expression Analysis of In Vitro Dedifferentiated Human Pancreatic Islet Cells Reveals the Activation of the Pluripotency-Related MicroRNA Cluster miR-302s
201818 citationsauthor #8
Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors
2018211 citationsauthor #25
Conventional and neo-antigenic peptides presented by β cells are preferentially targeted in the pancreas , but not in blood , of type 1 diabetic patients
20180 citationsauthor #28
Fighting diabetic foot ulcers-The diabetologist: A king maker of the fight.
20188 citationsauthor #6
MicroRNAs: markers of &bgr;-cell stress and autoimmunity
201823 citationsauthor #1
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.
2017233 citationsauthor #40
The map of diabetes and its determinants within the metropolitan area of Rome
20171 citationsauthor #6
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells
201737 citationsauthor #11
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity.
201728 citationsauthor #55
Selective expresssion of one specific isoform of the coxsackie adenovirus receptor (CAR) in the human pancreatic beta cells
20170 citationsauthor #4
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial
2017463 citationsauthor #4
Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p
201782 citationsauthor #7
miRNAs transferred by exosomes from T lymphocytes to beta cells contribute to type 1 diabetes development
20170 citationsauthor #7
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression
201758 citationsauthor #13
Clinical and experimental evidence suggest a protective effect of Paget's disease of bone against skeletal metastasization from solid tumors
20160 citationsauthor #9
FGF23 and SCL are expressed in carotid plaques and the association between their circulating fractions and fractures differs in relation to comorbidity in elderly individuals
20160 citationsauthor #14
Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells.
201626 citationsauthor #10
Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 3)
201619 citationsauthor #5
Erectile dysfunction and diabetes: Association with the impairment of lipid metabolism and oxidative stress.
201617 citationsauthor #6
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10–Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells
201665 citationsauthor #12
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells
201697 citationsauthor #11
Micro-RNA expression profiling in Paget's disease of bone
20163 citationsauthor #10
Tyrosine Phosphatase-Related Islet Antigen 2 Autoantibodies, the Only Marker of Islet Autoimmunity That Increases by Increasing the Degree of BMI in Obese Type 2 Diabetic Subjects
20150 citationsauthor #7
Towards an Earlier and Timely Diagnosis of Type 1 Diabetes: Is it Time to Change Criteria to Define Disease Onset?
20157 citationsauthor #3
Tyrosine Phosphatase–Related Islet Antigen 2(256–760) Autoantibodies, the Only Marker of Islet Autoimmunity That Increases by Increasing the Degree of BMI in Obese Subjects With Type 2 Diabetes
201532 citationsauthor #7
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
201547 citationsauthor #6
MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes
201557 citationsauthor #4
The social burden of hypoglycemia in the elderly
201541 citationsauthor #5
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients
20157 citationsauthor #7
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion
2015130 citationsauthor #11
Combination of serum miRNA-190 and -95 is a powerful non-invasive tool in the differential diagnosis of thyroid nodules: preliminary data of a prospective series
20150 citationsauthor #7
Mast cells infiltrate pancreatic islets in human type 1 diabetes
201557 citationsauthor #11
Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo
201544 citationsauthor #6
Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice
2014145 citationsauthor #13
Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population.
201456 citationsauthor #7

TIMELINE

1986 9 citations

1987 51 citations

1988 32 citations

1989 81 citations

1990 2 citations

1992 50 citations

1993 24 citations

1994 2 citations

1995 26 citations

1996 94 citations

1997 54 citations

1998 31 citations

1999 41 citations

2000 107 citations

2001 25 citations

2002 709 citations

2003 629 citations

2004 273 citations

2005 1,314 citations

2006 26 citations

2007 580 citations

2008 219 citations

2009 201 citations

2010 625 citations

2011 215 citations

2012 1,534 citations

2013 511 citations

2014 343 citations

2015 422 citations

2016 227 citations

2017 902 citations

2018 2,342 citations

2019 529 citations

2020 304 citations

2021 237 citations

2022 213 citations

2023 166 citations

F. Dotta

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT